C₂n Diagnostics

Developer of diagnostics and therapies for Alzheimer's disease

placeSt. Louis, Missouri, United States calendar_todayFounded 2007 groups41 employees language c2n.com

Social engagement

Social engagement: 11K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Eisai.

Investor typeCountShare
Venture capital113%
Other / undisclosed788%
Coming soon